Navigating the Insurance Landscape for Coverage of Reduction Mammaplasty.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 3 11 2020
pubmed: 4 11 2020
medline: 16 12 2020
Statut: ppublish

Résumé

Reduction mammaplasty provides symptomatic relief to patients with macromastia. Insurance companies act as gatekeepers of health care by determining the medical necessity of surgical procedures, including reduction mammaplasty. The authors sought to evaluate insurance coverage and policy criteria for reduction mammaplasty. The authors conducted a cross-sectional analysis of U.S. insurance policies on reduction mammaplasty. Insurance providers were selected based on their enrolment data and market share. The authors conducted telephone interviews and Web-based searches to identify the policies. Medical necessity criteria were abstracted from the publicly available policies that offered coverage. The authors reviewed 63 insurers. One in 10 insurers had no established policy for reduction mammaplasty. Of the 48 publicly available policies, shoulder pain and backache were the most common symptoms required for preapproval (98 percent and 98 percent). A minimum resection volume was requested by 88 percent of policies. One-third of policies (31 percent) offered a choice between removal of a minimum weight per breast or a volume based on body surface area. Over half of companies (54 percent) used body surface area calculations to predict minimum resection volume. Medical necessity that extended beyond national recommendations included trial of weight loss (23 percent) and nipple position (10 percent). Insurance policy criteria for reduction mammaplasty are discordant with current national recommendations and current clinical evidence. Many policies use outdated criteria that do not correlate with symptom relief and consequently limit access to reduction mammaplasty. Here, the authors propose a comprehensive guideline to maximize coverage of reduction mammaplasty.

Sections du résumé

BACKGROUND
Reduction mammaplasty provides symptomatic relief to patients with macromastia. Insurance companies act as gatekeepers of health care by determining the medical necessity of surgical procedures, including reduction mammaplasty. The authors sought to evaluate insurance coverage and policy criteria for reduction mammaplasty.
METHODS
The authors conducted a cross-sectional analysis of U.S. insurance policies on reduction mammaplasty. Insurance providers were selected based on their enrolment data and market share. The authors conducted telephone interviews and Web-based searches to identify the policies. Medical necessity criteria were abstracted from the publicly available policies that offered coverage.
RESULTS
The authors reviewed 63 insurers. One in 10 insurers had no established policy for reduction mammaplasty. Of the 48 publicly available policies, shoulder pain and backache were the most common symptoms required for preapproval (98 percent and 98 percent). A minimum resection volume was requested by 88 percent of policies. One-third of policies (31 percent) offered a choice between removal of a minimum weight per breast or a volume based on body surface area. Over half of companies (54 percent) used body surface area calculations to predict minimum resection volume. Medical necessity that extended beyond national recommendations included trial of weight loss (23 percent) and nipple position (10 percent).
CONCLUSIONS
Insurance policy criteria for reduction mammaplasty are discordant with current national recommendations and current clinical evidence. Many policies use outdated criteria that do not correlate with symptom relief and consequently limit access to reduction mammaplasty. Here, the authors propose a comprehensive guideline to maximize coverage of reduction mammaplasty.

Identifiants

pubmed: 33141528
doi: 10.1097/PRS.0000000000007241
pii: 00006534-202011000-00007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

539e-547e

Références

International Society of Aesthetic Plastic SurgeryISAPS international survey on aesthetic/cosmetic procedures. Available at: https://www.isaps.org/wp-content/uploads/2019/12/ISAPS-Global-Survey-Results-2018-new.pdf. Accessed December 5, 2019
American Society of Plastic Surgeons2018 national plastic surgery statistics. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-report-2018.pdf. Accessed December 5, 2019
Kerrigan CL, Collins ED, Kim HM, et al. Reduction mammaplasty: Defining medical necessity. Med Decis Making. 2002;22:208–217.
Benditte-Klepetko H, Leisser V, Paternostro-Sluga T, et al. Hypertrophy of the breast: A problem of beauty or health? J Womens Health (Larchmt.). 2007;16:1062–1069.
Kalliainen LK; ASPS Health Policy Committee. ASPS clinical practice guideline summary on reduction mammaplasty. Plast Reconstr Surg. 2012;130:785–789.
Singh KA, Losken A. Additional benefits of reduction mammaplasty: A systematic review of the literature. Plast Reconstr Surg. 2012;129:562–570.
Mello AA, Domingos NA, Miyazaki MC. Improvement in quality of life and self-esteem after breast reduction surgery. Aesthetic Plast Surg. 2010;34:59–64.
Lonie S, Sachs R, Shen A, Hunter-Smith DJ, Rozen WM, Seifman M. A systematic review of patient reported outcome measures for women with macromastia who have undergone breast reduction surgery. Gland Surg. 2019;8:431–440.
Ngaage LM, Bai J, Gebran S, et al. A 12-year review of patient-reported outcomes after reduction mammoplasty in patients with high body mass index. Medicine (Baltimore). 2019;98:e16055.
Bai J, Rosen CM, Ngaage LM, et al. Longevity of outcomes following reduction mammoplasty. Eplasty. 2019;19:e18.
Rogliani M, Gentile P, Labardi L, Donfrancesco A, Cervelli V. Improvement of physical and psychological symptoms after breast reduction. J Plast Reconstr Aesthet Surg. 2009;62:1647–1649.
Becker H. Breast reduction insurance denials. Plast Reconstr Surg. 2004;114:1687.
Rosen CM, Ngaage LM, Rada EM, Slezak S, Kavic S, Rasko Y. Surgical management of diastasis recti: A systematic review of insurance coverage in the United States. Ann Plast Surg. 2019;83:475–480.
Rasko YM, Rosen C, Ngaage LM, et al. Surgical management of gynecomastia: A review of the current insurance coverage criteria. Plast Reconstr Surg. 2019;143:1361–1368.
Ngaage LM, Knighton BJ, McGlone KL, et al. Health insurance coverage of gender-affirming top surgery in the United States. Plast Reconstr Surg. 2019;144:824–833.
Ngaage LM, Rose JA, Pace L, et al.A national overview of insurance coverage of post-bariatric upper body lift. Aesthetic Plast Surg. 2019;43:1250–1256.
Nguyen JT, Wheatley MJ, Schnur PL, Nguyen TA, Winn SR. Reduction mammaplasty: A review of managed care medical policy coverage criteria. Plast Reconstr Surg. 2008;121:1092–1100.
Wagner DS, Alfonso DR. The influence of obesity and volume of resection on success in reduction mammaplasty: An outcomes study. Plast Reconstr Surg. 2005;115:1034–1038.
American Society of Plastic SurgeonsASPS recommended insurance coverage criteria for third-party payers: Reduction mammaplasty. Available at: https://www.plasticsurgery.org/Documents/Health-Policy/Reimbursement/insurance-2017-reduction-mammaplasty.pdf. Accessed December 3, 2019
Henry J. Kaiser FoundationMarket share and enrolment of largest three insurers: Individual market. Available at: https://www.kff.org/private-insurance/state-indicator/market-share-and-enrollment-of-largest-three-insurers-individual-market/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed August 2, 2019
National Association of Insurance Commissioners2017 market share reports for the top 125 accident and health insurance groups and companies by state and countrywide. Available at: https://www.naic.org/prod_serv/MSR-PB-18.pdf. Accessed August 2, 2019
Coffron MR, Zlatos C. Medicare physician payment on the decline: It’s not your imagination. Available at: http://bulletin.facs.org/2019/09/medicare-physician-payment-on-the-decline-its-not-your-imagination/. Accessed December 5, 2019
Alderman AK, Storey AF, Nair NS, Chung KC. Financial impact of breast reconstruction on an academic surgical practice. Plast Reconstr Surg. 2009;123:1408–1413.
Alderman AK, Atisha D, Streu R, et al. Patterns and correlates of postmastectomy breast reconstruction by U.S. plastic surgeons: Results from a national survey. Plast Reconstr Surg. 2011;127:1796–1803.
Payatakes AH, Zagoreos NP, Fedorcik GG, Ruch DS, Levin LS. Current practice of microsurgery by members of the American Society for Surgery of the Hand. J Hand Surg Am. 2007;32:541–547.
Kaura AS, Berlin NL, Momoh AO, Kozlow JH. State variations in public payer reimbursement for common plastic surgery procedures. Plast Reconstr Surg. 2018;142:1653–1661.
Mabry CD, Gurien LA, Smith SD, Mehl SC. Are surgeons being paid fairly by Medicaid? A national comparison of typical payments for general surgeons. J Am Coll Surg. 2016;222:387–394.
Frey JD, Koltz PF, Bell DE, Langstein HN. The complex insurance reimbursement landscape in reduction mammaplasty: How does the American plastic surgeon navigate it? Ann Plast Surg. 2014;72:23–29.
Cabral IV, Garcia ED, Sobrinho RN, et al. Increased capacity for work and productivity after breast reduction. Aesthet Surg J. 2017;37:57–62.
Kung TA, Ahmed R, Kang CO, Cederna PS, Kozlow JH. Accuracy of predicted resection weights in breast reduction surgery. Plast Reconstr Surg Glob Open. 2018;6:e1830.
Schnur PL, Hoehn JG, Ilstrup DM, Cahoy MJ, Chu CP. Reduction mammaplasty: Cosmetic or reconstructive procedure? Ann Plast Surg. 1991;27:232–237.
Boukovalas S, Padilla PL, Spratt H, et al. Redefining the role of resection weight prediction in reduction mammaplasty and breaking the “one-scale-fits-all” paradigm. Plast Reconstr Surg. 2019;144:18e–27e.
Wampler A, Powelson I, Matthew MK. Comparative accuracy of clinical and formula-based estimation of resection weight in reduction mammoplasty and implications for insurance preapproval and payment. Ann Plast Surg. 2019;82Suppl 3S259–S263.
Schnur PL. Reduction mammaplasty: The Schnur sliding scale revisited. Ann Plast Surg. 1999;42:107–108.
Strong B, Hall-Findlay EJ. How does volume of resection relate to symptom relief for reduction mammaplasty patients? Ann Plast Surg. 2015;75:376–382.
Spector JA, Singh SP, Karp NS. Outcomes after breast reduction: Does size really matter? Ann Plast Surg. 2008;60:505–509.
Setälä L, Papp A, Joukainen S, et al.Obesity and complications in breast reduction surgery: Are restrictions justified? J Plast Reconstr Aesthet Surg. 2009;62:195–199.
Zubowski R, Zins JE, Foray-Kaplon A, et al. Relationship of obesity and specimen weight to complications in reduction mammaplasty. Plast Reconstr Surg. 2000;106:998–1003.
Xue AS, Wolfswinkel EM, Weathers WM, Chike-Obi C, Heller L. Breast reduction in adolescents: Indication, timing, and a review of the literature. J Pediatr Adolesc Gynecol. 2013;26:228–233.
Soleimani T, Evans TA, Sood R, et al. Pediatric reduction mammaplasty: A retrospective analysis of the Kids’ Inpatient Database (KID). Surgery. 2015;158:793–801.
Hudson DA, Lelala NB. Anthropometric changes in a prospective study of 100 patients requesting breast reduction. Plast Reconstr Surg Glob Open. 2019;7:e2150.
Coltman CE, Steele JR, McGhee DE. Can breast characteristics predict upper torso musculoskeletal pain? Clin Biomech (Bristol, Avon). 2018;53:46–53.
Chao JD, Memmel HC, Redding JF, Egan L, Odom LC, Casas LA. Reduction mammaplasty is a functional operation, improving quality of life in symptomatic women: A prospective, single-center breast reduction outcome study. Plast Reconstr Surg. 2002;110:1644–1652; discussion 1653–1654.
Puhl RM, Heuer CA. The stigma of obesity: A review and update. Obesity (Silver Spring). 2009;17:941–964.
Shah R, Al-Ajam Y, Stott D, Kang N. Obesity in mammaplasty: A study of complications following breast reduction. J Plast Reconstr Aesthet Surg. 2011;64:508–514.
Gonzalez F, Walton RL, Shafer B, Matory WE Jr, Borah GL. Reduction mammaplasty improves symptoms of macromastia. Plast Reconstr Surg. 1993;91:1270–1276.
Hernanz F, Fidalgo M, Muñoz P, Noriega MG, Gómez-Fleitas M. Impact of reduction mammoplasty on the quality of life of obese patients suffering from symptomatic macromastia: A descriptive cohort study. J Plast Reconstr Aesthet Surg. 2016;69:e168–e173.
Harding M. The power of advocacy for positive change. Obesity Canada. Available at: https://obesitycanada.ca/oc-news/the-power-of-advocacy-for-positive-change/. Accessed December 3, 2019

Auteurs

Catherine M A Rawes (CMA)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Ledibabari M Ngaage (LM)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Mimi R Borrelli (MR)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Joseph Puthumana (J)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Sheri Slezak (S)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Yvonne M Rasko (YM)

From the Yorkshire and Humber Foundation School; the Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine; and Stanford University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH